Xavier Valette
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Xavier Valette has a total of 122 co-authors. Here are the top co-authors by number of shared publications:
Damien du Cheyron
Department of Medical Intensive Care, CHU de Caen Normandie, 14000 Caen, France
14 shared publications- Nicolas Terzi
Médecine Intensive – Réanimation, CHU de Rennes, Rennes, France
10 shared publications Amélie Seguin
8 shared publicationsCédric Daubin
University Hospital
6 shared publications- Damien du Cheyron
CHU de Caen
6 shared publications Bertrand Sauneuf
5 shared publications
Latest Publications
- 12 August 2025
- Published by Springer Nature in Intensive Care Medicine
- Vol. 51 (9) , 1587-1602
Hemodynamic and neurological presentations of invasive meningococcal disease in adults: a nationwide study across 100+ French ICUs
Purpose Invasive meningococcal disease (IMD) is a rare but potentially fatal infection caused by Neisseria meningitidis. In adults requiring admission to intensive care unit (ICU), IMD typically presents with two distinct clinical presentations: neurological (meningitis) and hemodynamic (sepsis). These presentations are often conflated, despite the differences in pathophysiology and outcome. Methods RETRO-MENINGO is a nationwide, multicentre, retrospective cohort study conducted in 102 French ICUs between January 1, 2016, and December 31, 2024. Adults (≥ 18 years) admitted to the ICU with a microbiologically confirmed IMD were categorised as having either a neurological or a hemodynamic presentation according to the main reason for ICU admission. The primary outcome was day-60 mortality in each presentation. Results Of 654 patients (median age 33 years [IQR 21–56]; 63.5% without comorbidities), 407 (62%) had a neurological and 247 (38%) a hemodynamic presentation at ICU admission. Hemodynamic presentation was associated with older age (39.0 vs. 30.0 years; p = 0.001), immunosuppression (17.0% vs. 7.1%; p < 0.001), purpuric rash (55.9% vs. 43.7%; p = 0.003), earlier ICU admission (1 vs. 2 days; p = 0.001) and more frequent bacteremia (83.8% vs. 35.6%; p < 0.001). Serogroup B was predominant in neurological presentation, whereas serogroup W135 was more common in hemodynamic presentation. Compared to neurological presentation, hemodynamic presentation required more organ support (vasopressors, invasive mechanical ventilation, transfusions, renal replacement therapy) and had a significantly higher day-60 mortality (25.5% vs. 4.7%; p < 0.001). Hemodynamic presentation (aOR 4.33, 95% CI 2.26–8.62; p < 0.001), absence of comorbidities (aOR 2.21, 95% CI 1.19–4.23; p = 0.014), age > 35 years (aOR 3.65, 95% CI 1.73–6.07; p < 0.001), arterial lactate level > 5 mmol/L (aOR 2.60, 95% CI 1.43–4.77; p = 0.002) and symptom onset < 24 h (aOR 1.90, 95% CI 1.00–3.55; p = 0.040) were independently associated with day-60 mortality, while early administration of a parenteral third-generation cephalosporin prior to ICU admission was strongly protective (aOR 0.31, 95% CI 0.18–0.55; p < 0.001). Conclusion Neurological and hemodynamic presentation of IMD are clinically and prognostically distinct. Recognition of these phenotypes is critical for appropriate management and prediction of outcome.
- 12 August 2025
- Published by Springer Nature in Intensive Care Medicine
- Vol. 51 (9) , 1587-1602
Hemodynamic and neurological presentations of invasive meningococcal disease in adults: a nationwide study across 100+ French ICUs
Purpose Invasive meningococcal disease (IMD) is a rare but potentially fatal infection caused by Neisseria meningitidis. In adults requiring admission to intensive care unit (ICU), IMD typically presents with two distinct clinical presentations: neurological (meningitis) and hemodynamic (sepsis). These presentations are often conflated, despite the differences in pathophysiology and outcome. Methods RETRO-MENINGO is a nationwide, multicentre, retrospective cohort study conducted in 102 French ICUs between January 1, 2016, and December 31, 2024. Adults (≥ 18 years) admitted to the ICU with a microbiologically confirmed IMD were categorised as having either a neurological or a hemodynamic presentation according to the main reason for ICU admission. The primary outcome was day-60 mortality in each presentation. Results Of 654 patients (median age 33 years [IQR 21–56]; 63.5% without comorbidities), 407 (62%) had a neurological and 247 (38%) a hemodynamic presentation at ICU admission. Hemodynamic presentation was associated with older age (39.0 vs. 30.0 years; p = 0.001), immunosuppression (17.0% vs. 7.1%; p < 0.001), purpuric rash (55.9% vs. 43.7%; p = 0.003), earlier ICU admission (1 vs. 2 days; p = 0.001) and more frequent bacteremia (83.8% vs. 35.6%; p < 0.001). Serogroup B was predominant in neurological presentation, whereas serogroup W135 was more common in hemodynamic presentation. Compared to neurological presentation, hemodynamic presentation required more organ support (vasopressors, invasive mechanical ventilation, transfusions, renal replacement therapy) and had a significantly higher day-60 mortality (25.5% vs. 4.7%; p < 0.001). Hemodynamic presentation (aOR 4.33, 95% CI 2.26–8.62; p < 0.001), absence of comorbidities (aOR 2.21, 95% CI 1.19–4.23; p = 0.014), age > 35 years (aOR 3.65, 95% CI 1.73–6.07; p < 0.001), arterial lactate level > 5 mmol/L (aOR 2.60, 95% CI 1.43–4.77; p = 0.002) and symptom onset < 24 h (aOR 1.90, 95% CI 1.00–3.55; p = 0.040) were independently associated with day-60 mortality, while early administration of a parenteral third-generation cephalosporin prior to ICU admission was strongly protective (aOR 0.31, 95% CI 0.18–0.55; p < 0.001). Conclusion Neurological and hemodynamic presentation of IMD are clinically and prognostically distinct. Recognition of these phenotypes is critical for appropriate management and prediction of outcome.
- Open Access
- 6 August 2025
- Published by Wolters Kluwer Health in Critical Care Explorations
- Vol. 7 (8) , e1300
Life-Supporting Treatment Limitations in Patients Who Die Within 48 Hours After ICU Admission: A French, Multicenter, Observational, Exploratory Study
IMPORTANCE: The occurrence of death shortly after ICU admission raises concerns about the appropriateness of providing intensive care to frail patients—many of whom are subsequently subject to decisions to limit life-supporting treatment limitation (LST-L). The proportion of patients who die early and are affected by such limitations remains unknown. OBJECTIVES: The primary objective was to determine the proportion of patients with a decision of LST-L among patients who died within 48 hours after ICU admission. We also conducted analyses to identify variables associated with LST-L and collected staff perceptions. DESIGN, SETTING, AND PARTICIPANTS: A retrospective, observational, multicenter study with data collected immediately after the patient’s death, according to predefined criteria. The study was conducted in 12 ICUs in France. Consecutive patients who died within 48 hours of ICU admission during the study period, in 2022–2023, were included. LST-L decisions were not guided by protocols but were at the discretion of the attending intensivists. MAIN OUTCOMES AND MEASURES: Of 1615 patients admitted to the participating ICUs during the study period, 100 died (6.2%) within 48 hours, including 62 with LST-L. RESULTS: In the LST-L group, age was significantly older (72 yr [64–77.8 yr] vs. 63 yr [59.0–69.8 yr]; p = 0.002), Charlson Comorbidity Index significantly higher (5.5 [2.0–8.0] vs. 4.0 [2.0–5.0]; p < 0.001), and management less invasive compared with the full-care group. By multivariable analysis, male patients were less likely to have LST-L decisions (odds ratio, 0.35; 95% CI, 0.13–0.93; p = 0.03). Most physicians, but a smaller proportion of nurses, perceived LST-L decisions as consensual. For 28 of 100 patients, the intensivist retrospectively deemed the ICU admission not the most suitable option. Patient wishes were rarely considered when making LST-L decisions. Time-limited trials were rarely used. Two-thirds of LST-L decisions were made during on-call hours. CONCLUSIONS AND RELEVANCE: Deaths occurring shortly after ICU admission were usually preceded by LST-L decisions. Efforts are needed to better consider patients’ wishes and to strengthen communication between ICU physicians and nursing staff, to ensure appropriate care—even when patients’ wishes are unknown and alternatives to ICU admission are not straightforward. Such rare and sometimes unforeseeable cases may also reflect unspoken preferences of patients or their families.
- 6 August 2025
- Published by Wolters Kluwer Health in Critical Care Explorations
- Vol. 7 (8) , e1300
Open AccessLife-Supporting Treatment Limitations in Patients Who Die Within 48 Hours After ICU Admission: A French, Multicenter, Observational, Exploratory Study
IMPORTANCE: The occurrence of death shortly after ICU admission raises concerns about the appropriateness of providing intensive care to frail patients—many of whom are subsequently subject to decisions to limit life-supporting treatment limitation (LST-L). The proportion of patients who die early and are affected by such limitations remains unknown. OBJECTIVES: The primary objective was to determine the proportion of patients with a decision of LST-L among patients who died within 48 hours after ICU admission. We also conducted analyses to identify variables associated with LST-L and collected staff perceptions. DESIGN, SETTING, AND PARTICIPANTS: A retrospective, observational, multicenter study with data collected immediately after the patient’s death, according to predefined criteria. The study was conducted in 12 ICUs in France. Consecutive patients who died within 48 hours of ICU admission during the study period, in 2022–2023, were included. LST-L decisions were not guided by protocols but were at the discretion of the attending intensivists. MAIN OUTCOMES AND MEASURES: Of 1615 patients admitted to the participating ICUs during the study period, 100 died (6.2%) within 48 hours, including 62 with LST-L. RESULTS: In the LST-L group, age was significantly older (72 yr [64–77.8 yr] vs. 63 yr [59.0–69.8 yr]; p = 0.002), Charlson Comorbidity Index significantly higher (5.5 [2.0–8.0] vs. 4.0 [2.0–5.0]; p < 0.001), and management less invasive compared with the full-care group. By multivariable analysis, male patients were less likely to have LST-L decisions (odds ratio, 0.35; 95% CI, 0.13–0.93; p = 0.03). Most physicians, but a smaller proportion of nurses, perceived LST-L decisions as consensual. For 28 of 100 patients, the intensivist retrospectively deemed the ICU admission not the most suitable option. Patient wishes were rarely considered when making LST-L decisions. Time-limited trials were rarely used. Two-thirds of LST-L decisions were made during on-call hours. CONCLUSIONS AND RELEVANCE: Deaths occurring shortly after ICU admission were usually preceded by LST-L decisions. Efforts are needed to better consider patients’ wishes and to strengthen communication between ICU physicians and nursing staff, to ensure appropriate care—even when patients’ wishes are unknown and alternatives to ICU admission are not straightforward. Such rare and sometimes unforeseeable cases may also reflect unspoken preferences of patients or their families.
- 3 February 2025
- Published by Springer Nature in Intensive Care Medicine
- Vol. 51 (4) , 779-782
Understanding the disease: euglycemic ketoacidosis with SGLT2 inhibitors
- 3 February 2025
- Published by Springer Nature in Intensive Care Medicine
- Vol. 51 (4) , 779-782
Understanding the disease: euglycemic ketoacidosis with SGLT2 inhibitors
- 1 November 2020
- Published by Elsevier in The Lancet Infectious Diseases
- Vol. 20 (11) , 1230
Mediastinal lymphadenopathy in patients with severe COVID-19
- 1 November 2020
- Published by Elsevier in The Lancet Infectious Diseases
- Vol. 20 (11) , 1230
Mediastinal lymphadenopathy in patients with severe COVID-19
- 5 August 2020
- Published by Wiley in Echocardiography
- Vol. 37 (8) , 1171-1176
Subcostal versus transhepatic view to assess the inferior vena cava in critically ill patients
Background: Evaluation of the inferior vena cava (IVC) is not always possible through the subcostal (SC) window.Methods: Inferior vena cava diameters measured by transhepatic (TH) and SC views were compared by Bland and Altman analysis.Results: 131 patients were enrolled, including 88 (67%) under mechanical ventilation. The echogenicity was statistically poorer through the TH view in comparison with the SC view (P = .002). The correlation between the SC and TH views was good and better for respiratory variation than for end‐expiratory or end‐inspiratory diameter measurements (r = 0.86). Despite low bias, the limits of agreement were wide (−7.5 and 7.7 mm for end‐expiratory diameter, −8.7 and 8.5 mm for end‐inspiratory diameter, and −5.3 and 5.8 mm for respiratory variation). Complementary analysis showed that the concordance between the SC and the TH views was better when the IVC was distended. However, the limits of agreement remained broad.Conclusions: Although feasible in almost all patients, the TH view does not provide better echogenicity in comparison with the SC view. Despite a good correlation with the SC view and a low bias, the limits of agreement were wide, especially when the IVC has an ellipsoidal shape, suggesting caution in the interpretation of data obtained by the TH view.
- 5 August 2020
- Published by Wiley in Echocardiography
- Vol. 37 (8) , 1171-1176
Subcostal versus transhepatic view to assess the inferior vena cava in critically ill patients
Background: Evaluation of the inferior vena cava (IVC) is not always possible through the subcostal (SC) window.Methods: Inferior vena cava diameters measured by transhepatic (TH) and SC views were compared by Bland and Altman analysis.Results: 131 patients were enrolled, including 88 (67%) under mechanical ventilation. The echogenicity was statistically poorer through the TH view in comparison with the SC view (P = .002). The correlation between the SC and TH views was good and better for respiratory variation than for end‐expiratory or end‐inspiratory diameter measurements (r = 0.86). Despite low bias, the limits of agreement were wide (−7.5 and 7.7 mm for end‐expiratory diameter, −8.7 and 8.5 mm for end‐inspiratory diameter, and −5.3 and 5.8 mm for respiratory variation). Complementary analysis showed that the concordance between the SC and the TH views was better when the IVC was distended. However, the limits of agreement remained broad.Conclusions: Although feasible in almost all patients, the TH view does not provide better echogenicity in comparison with the SC view. Despite a good correlation with the SC view and a low bias, the limits of agreement were wide, especially when the IVC has an ellipsoidal shape, suggesting caution in the interpretation of data obtained by the TH view.
- 1 July 2020
- Published by Elsevier in The Lancet Rheumatology
- Vol. 2 (7) , e382-E382
Anakinra for patients with COVID-19
- 1 July 2020
- Published by Elsevier in The Lancet Rheumatology
- Vol. 2 (7) , e382-E382
Anakinra for patients with COVID-19
- 18 October 2019
- Published by Springer Nature in Intensive Care Medicine
- Vol. 46 (2) , 381-382
Diffuse varicella zoster virus reactivation in critically ill immunocompromised patient
- 18 October 2019
- Published by Springer Nature in Intensive Care Medicine
- Vol. 46 (2) , 381-382
Diffuse varicella zoster virus reactivation in critically ill immunocompromised patient
- 23 May 2018
- Published by Springer Nature in Intensive Care Medicine
- Vol. 44 (5) , 694
Brownout: another threat to ICU physicians and nurses
- 23 May 2018
- Published by Springer Nature in Intensive Care Medicine
- Vol. 44 (5) , 694
Brownout: another threat to ICU physicians and nurses
- 30 November 2017
- Published by Springer Nature in Intensive Care Medicine
- Vol. 44 (2) , 270-271
Is ticagrelor safe in intensive care unit patients? Focus on bradycardic events
- 30 November 2017
- Published by Springer Nature in Intensive Care Medicine
- Vol. 44 (2) , 270-271
Is ticagrelor safe in intensive care unit patients? Focus on bradycardic events
- Open Access
- 1 January 2016
- Published by Elsevier in Annals of Intensive Care
- Vol. 6 (1) , 65
Immature/total granulocyte ratio improves early prediction of neurological outcome after out-of-hospital cardiac arrest: the MyeloScore study
- 1 January 2016
- Published by Elsevier in Annals of Intensive Care
- Vol. 6 (1) , 65
Open AccessImmature/total granulocyte ratio improves early prediction of neurological outcome after out-of-hospital cardiac arrest: the MyeloScore study